Advertisements



Buying Celgene

Buying Celgene.....»»

Category: topSource: seekingalphaJan 11th, 2019

Celgene: Mr. Market Is Knocking, Presenting A Buying Opportunity

Celgene: Mr. Market Is Knocking, Presenting A Buying Opportunity.....»»

Category: topSource: seekingalphaJun 4th, 2018

Agios Pharmaceuticals, Inc.Stock Is an Analyst Darling for Good Reason

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Celgene buying out Agios would make sense but either .....»»

Category: topSource: investorplaceJun 5th, 2018

3 Real Risks That Could Make You Reconsider Buying Celgene Stock

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Celgene stock looks cheap. But there are dangers here as well. The post 3 Real Risks That Could Make You Reconsider Buying Celgene Stock appeared first on InvestorPlace......»»

Category: topSource: investorplaceJul 12th, 2018

Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever

It's one of the l.....»»

Category: europeSource: fortuneJan 3rd, 2019

Giant drug deal: Bristol-Myers Squibb buying Celgene for $74 billion

Bris.....»»

Category: topSource: bizjournalsJan 3rd, 2019

Bristol-Myers buys Celgene for $74 billion

Bristol-Myers Squibb is buying Celgene for about $74 billion, creating a major pharma company with several blockbuster cancer drugs as competition in the immunotherapy sector heats up. Fred Katayama reports......»»

Category: videoSource: reutersJan 3rd, 2019

Bristol-Myers Squibb Rings in the New Year by Buying Celgene for $74 Billion

Pharmaceutical giants enter first major deal of 2019Related Stocks: BMY, CELG,.....»»

Category: blogSource: gurufocusJan 3rd, 2019

Bristol-Myers to acquire Celgene in year’s first major pharma deal

Manhattan-based Bristol-Myers Squibb is buying fellow drugmaker Celgene in a cash and stock deal valued at $74 billion, with Bristol-Myers’ shareholders expected to own 69% of the combined entity. ["> To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkJan 3rd, 2019

Bristol-Myers to acquire Celgene in year’s first major pharma deal

Manhattan-based Bristol-Myers Squibb is buying fellow drugmaker Celgene in a cash and stock deal valued at $74 billion, with Bristol-Myers’ shareholders expected to own 69% of the combined entity.... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkJan 3rd, 2019

3 Reasons Buying Celgene Right Now Makes Sense

3 Reasons Buying Celgene Right Now Makes Sense.....»»

Category: futuresSource: nasdaqJan 9th, 2019

Buying Celgene

Buying Celgene.....»»

Category: topSource: seekingalphaJan 11th, 2019

Cities With The Oldest Homes

Many potential American homeowners dream about buying a brand new house, full of modern design elements and technology. Others, despite the risk of repairs, would much prefer an older house, steeped........»»

Category: blogSource: 247wallst8 min. ago

Cities With the Newest Homes

Many potential American homeowners dream about buying an older house, steeped in history and rustic charm. Others would much prefer a brand new home, with modern design elements and no need for major........»»

Category: blogSource: 247wallst23 min. ago

Breakingviews TV: Botox Tuesday

AbbVie is buying Allergan, maker of Botox, for $63 billion – a 45% premium. It’s a great deal for the seller’s shareholders, but not much more than an overpriced superficial filler for the buyer. Robert Cyran explains the wrinkles in the merger......»»

Category: videoSource: reuters23 min. ago

3 Small Biotech Stocks Insiders Are Buying

3 Small Biotech Stocks Insiders Are Buying.....»»

Category: topSource: seekingalpha1 hr. 23 min. ago

America"s Adversaries Are Buying Gold Like A Nuke Is Going Off Tomorrow

Having tested $1300 numerous time.....»»

Category: blogSource: zerohedge2 hr. 8 min. ago

Kraft Heinz: Now"s The Time To Consider Buying

Kraft Heinz: Now"s The Time To Consider Buying.....»»

Category: topSource: seekingalpha2 hr. 23 min. ago

What AbbVie’s $63 Billion Deal to Buy Allergan Says About the Drug Industry

AbbVie, maker of the world's best-selling drug, is buying Botox maker Allergan in a blockbuster deal. Here's what that says about the state of biopharma. A.....»»

Category: europeSource: fortune2 hr. 23 min. ago

Jeff Reeves"s Strength in Numbers: Only half of these big tech stocks are worth buying

Which big tech stocks are looking good in 2019 as they approach new highs, and which ones look like they may be falling behind? Jeff Reeves gives his picks......»»

Category: topSource: marketwatch4 hr. 8 min. ago

AbbVie buys Allergan for $63 bln

AbbVie, which produces the blockbuster drug Humira, is buying the maker of Botox, Allergan, for about $63 billion. As Fred Katayama reports, AbbVie was under pressure to diversify its lineup of drugs......»»

Category: videoSource: reuters4 hr. 23 min. ago